Zydus Lifesciences Ltd.
•₹ 1,1201.11%
2026-08-21
ABOUT
KEY POINTS
Revenue Breakup Mar 2026 • Pharmaceuticals: 82.6% • Consumer Products: 14.6% • Medical Technologies: 2.9%
PROS
- Company has a healthy return on capital (ROCE) of 24.1%
- Company has a good return on equity (ROE) track record: 3 Years ROE 20.4%
- Company has consistently been profitable over the last 5 years
- Working capital cycle has improved - days down from 64 to 30
- Company comfortably covers its interest (16.1x coverage)
- Company has a consistent dividend-paying track record
CONS
- Recent results are weak - TTM profit is down 16.9% versus prior year
- A large part of profit comes from other income (27.1% of PBT)
- Receivables are growing faster than sales - a possible quality concern
- Total debt has risen sharply - up 271.3% year on year
- Recurring exceptional / one-off items are inflating headline profit
* The pros and cons are machine generated based on quantitative rules.
Peer comparison
EDIT COLUMNS| S.No. | Name | CMP Rs. | P/E | Mar Cap Rs.Cr. | Div Yld % | NP Qtr Rs.Cr. | Qtr Profit Var % | Sales Qtr Rs.Cr. | Qtr Sales Var % | ROCE % | OPM % |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. | SUNPHARMA | 1898.00 | 37.65 | 455393.78 | 0.84 | 2901.23 | 26.53 | 15299.88 | 10.98 | 19.11 | 28.81 |
| 2. | DIVISLAB | 8525.00 | 77.37 | 226311.96 | 0.35 | 902.00 | 65.50 | 3080.00 | 27.80 | 21.51 | 40.75 |
| 3. | TORNTPHARM | 5013.00 | 87.43 | 190678.41 | 0.76 | 566.00 | 3.28 | 4921.00 | 57.32 | 19.27 | 33.81 |
| 4. | CIPLA | 1416.00 | 33.94 | 114392.01 | 0.92 | 785.55 | -39.18 | 7119.28 | 4.13 | 16.00 | 16.73 |
| 5. | ZYDUSLIFE | 1105.00 | 24.42 | 110224.17 | 0.09 | 990.20 | -34.90 | 8017.00 | 23.97 | 21.39 | 24.54 |
| 6. | LUPIN | 2220.00 | 18.36 | 101506.15 | 0.81 | 1416.98 | 16.01 | 8276.89 | 34.28 | 28.86 | 29.59 |
| 7. | MANKIND | 2391.00 | 48.34 | 98747.34 | 0.04 | 574.09 | 29.12 | 4030.59 | 12.89 | 13.24 | 26.30 |
| 8. | DRREDDY | 1171.00 | 30.33 | 97740.54 | 0.68 | 435.60 | -69.10 | 8099.80 | -5.21 | 13.75 | 10.63 |
| 9. | LAURUSLABS | 1807.00 | 89.30 | 97634.42 | 0.11 | 3620.70 | 2139.42 | 20263.10 | 1191.00 | 18.20 | 31.50 |
| 10. | AUROPHARMA | 1615.15 | 25.03 | 92932.16 | 0.25 | 1032.03 | 25.22 | 9150.35 | 17.44 | 12.76 | 20.54 |
| 11. | BIOCON | 414.30 | 136.32 | 67518.23 | 0.12 | 136.80 | 53.36 | 4336.00 | 10.89 | 3.26 | 19.54 |
| 12. | ALKEM | 5380.50 | 29.82 | 64331.95 | 0.98 | 520.98 | -22.00 | 3740.15 | 10.95 | 21.28 | 20.47 |
Detailed Comparison with:
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 5,053 | 4,259 | 4,344 | 5,366 | 6,046 | 5,114 | 5,124 | 6,290 | 6,467 | 6,038 | 6,780 | 7,434 | 8,017 | |
| 3,634 | 3,305 | 3,403 | 3,909 | 4,124 | 3,821 | 3,882 | 4,402 | 4,542 | 4,522 | 5,048 | 5,678 | 6,798 | |
| Operating Profit | — | — | — | — | — | — | — | — | — | — | — | — | — |
| OPM % | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Other Income | 36 | 136 | 38 | 162 | 63 | 114 | 58 | 81 | 212 | 523 | 111 | 779 | 106 |
| Interest | 18 | 9 | 20 | 35 | 32 | 25 | 32 | 77 | 85 | 101 | 130 | 123 | 156 |
| Depreciation | 180 | 184 | 195 | 205 | 215 | 234 | 229 | 238 | 238 | 302 | 360 | 508 | 555 |
| 1,329 | 1,007 | 926 | 1,547 | 1,900 | 1,271 | 1,184 | 1,672 | 1,921 | 1,687 | 1,353 | 1,660 | 1,344 | |
| Tax % | 16.26% | 22.48% | 23.10% | 20.76% | 22.96% | 29.36% | 15.16% | 25.31% | 22.60% | 26.91% | 28.69% | 19.18% | 26.35% |
| Net Profit | 0 | 0 | 0 | 0 | 1,482 | 920 | 1,026 | 1,244 | 1,521 | 1,239 | 1,023 | 1,341 | 990 |
| 11 | 8 | 8 | 12 | 14 | 9 | 10 | 12 | 15 | 13 | 10 | 13 | 1 | |
| Equity Capital | 101 | 101 | 101 | 101 | 101 | 101 | 101 | 101 | 101 | 101 | 101 | 101 | 100 |
| Reserves | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Promoter Pledge % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Equity Capital | 101 | 101 | 101 | 101 | 101 | 101 | 101 | 101 | 101 | 101 | 101 | 101 | 100 |
| Reserves | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Promoter Pledge % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Jun 2023
- 5,053
- 3,634
- Operating Profit
- —
- OPM %
- —
- Other Income
- 36
- Interest
- 18
- Depreciation
- 180
- 1,329
- Tax %
- 16.26%
- Net Profit
- 0
- 11
- Equity Capital
- 101
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 101
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Sep 2023
- 4,259
- 3,305
- Operating Profit
- —
- OPM %
- —
- Other Income
- 136
- Interest
- 9
- Depreciation
- 184
- 1,007
- Tax %
- 22.48%
- Net Profit
- 0
- 8
- Equity Capital
- 101
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 101
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Dec 2023
- 4,344
- 3,403
- Operating Profit
- —
- OPM %
- —
- Other Income
- 38
- Interest
- 20
- Depreciation
- 195
- 926
- Tax %
- 23.10%
- Net Profit
- 0
- 8
- Equity Capital
- 101
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 101
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Mar 2024
- 5,366
- 3,909
- Operating Profit
- —
- OPM %
- —
- Other Income
- 162
- Interest
- 35
- Depreciation
- 205
- 1,547
- Tax %
- 20.76%
- Net Profit
- 0
- 12
- Equity Capital
- 101
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 101
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Jun 2024
- 6,046
- 4,124
- Operating Profit
- —
- OPM %
- —
- Other Income
- 63
- Interest
- 32
- Depreciation
- 215
- 1,900
- Tax %
- 22.96%
- Net Profit
- 1,482
- 14
- Equity Capital
- 101
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 101
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Sep 2024
- 5,114
- 3,821
- Operating Profit
- —
- OPM %
- —
- Other Income
- 114
- Interest
- 25
- Depreciation
- 234
- 1,271
- Tax %
- 29.36%
- Net Profit
- 920
- 9
- Equity Capital
- 101
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 101
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Dec 2024
- 5,124
- 3,882
- Operating Profit
- —
- OPM %
- —
- Other Income
- 58
- Interest
- 32
- Depreciation
- 229
- 1,184
- Tax %
- 15.16%
- Net Profit
- 1,026
- 10
- Equity Capital
- 101
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 101
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Mar 2025
- 6,290
- 4,402
- Operating Profit
- —
- OPM %
- —
- Other Income
- 81
- Interest
- 77
- Depreciation
- 238
- 1,672
- Tax %
- 25.31%
- Net Profit
- 1,244
- 12
- Equity Capital
- 101
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 101
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Jun 2025
- 6,467
- 4,542
- Operating Profit
- —
- OPM %
- —
- Other Income
- 212
- Interest
- 85
- Depreciation
- 238
- 1,921
- Tax %
- 22.60%
- Net Profit
- 1,521
- 15
- Equity Capital
- 101
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 101
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Sep 2025
- 6,038
- 4,522
- Operating Profit
- —
- OPM %
- —
- Other Income
- 523
- Interest
- 101
- Depreciation
- 302
- 1,687
- Tax %
- 26.91%
- Net Profit
- 1,239
- 13
- Equity Capital
- 101
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 101
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Dec 2025
- 6,780
- 5,048
- Operating Profit
- —
- OPM %
- —
- Other Income
- 111
- Interest
- 130
- Depreciation
- 360
- 1,353
- Tax %
- 28.69%
- Net Profit
- 1,023
- 10
- Equity Capital
- 101
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 101
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Mar 2026
- 7,434
- 5,678
- Operating Profit
- —
- OPM %
- —
- Other Income
- 779
- Interest
- 123
- Depreciation
- 508
- 1,660
- Tax %
- 19.18%
- Net Profit
- 1,341
- 13
- Equity Capital
- 101
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 101
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Jun 2026
- 8,017
- 6,798
- Operating Profit
- —
- OPM %
- —
- Other Income
- 106
- Interest
- 156
- Depreciation
- 555
- 1,344
- Tax %
- 26.35%
- Net Profit
- 990
- 1
- Equity Capital
- 100
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 100
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 9,376 | 11,905 | 13,166 | 14,253 | 14,404 | 15,110 | 17,237 | 19,547 | 23,242 | 27,148 | 28,270 | |
| 7,472 | 9,058 | 10,187 | 11,473 | 11,018 | 11,935 | 13,666 | 14,248 | 16,348 | 19,958 | 22,045 | |
| Operating Profit | 2,051 | 2,980 | 3,187 | 2,897 | 3,460 | 3,565 | 4,046 | 5,668 | 7,353 | 8,985 | — |
| OPM % | 22 | 25 | 24 | 20 | 24 | 24 | 23 | 29 | 32 | 33 | — |
| Other Income | 147 | 133 | 208 | 117 | 75 | 391 | 475 | 369 | 460 | 1,795 | 1,520 |
| Interest | 63 | 111 | 196 | 342 | 186 | 127 | 130 | 81 | 191 | 439 | 510 |
| Depreciation | 373 | 539 | 599 | 696 | 670 | 713 | 723 | 764 | 916 | 1,408 | 1,725 |
| 1,615 | 2,331 | 2,382 | 1,495 | 2,399 | 2,838 | 2,590 | 4,809 | 6,027 | 6,621 | 6,045 | |
| Tax % | 8 | 24 | 22 | 21 | 8 | 18 | 23 | 20 | 23 | 24 | 25 |
| Net Profit | 1,486 | 1,766 | 1,852 | 1,176 | 2,206 | 2,326 | 2,002 | 3,831 | 4,615 | 5,026 | 4,530 |
| EPS | 15 | 17 | 18 | 11 | 21 | 44 | 19 | 38 | 45 | 50 | — |
| Dividend Payout % | 22 | 20 | 19 | 30 | 17 | 6 | 31 | 8 | 24 | 2 | — |
| Minority Interest | -29 | -35 | -50 | -28 | -51 | -131 | -132 | -113 | -147 | -84 | 48 |
| Share of Associates | 34 | 63 | 47 | 29 | 47 | 46 | 95 | 118 | 58 | 97 | 100 |
| Adjusted EPS | 15 | 17 | 18 | 11 | 21 | 44 | 19 | 38 | 45 | 50 | — |
| Minority Interest | -29 | -35 | -50 | -28 | -51 | -131 | -132 | -113 | -147 | -84 | 48 |
| Share of Associates | 34 | 63 | 47 | 29 | 47 | 46 | 95 | 118 | 58 | 97 | 100 |
| Adjusted EPS | 15 | 17 | 18 | 11 | 21 | 44 | 19 | 38 | 45 | 50 | — |
Mar 2017
- 9,376
- 7,472
- Operating Profit
- 2,051
- OPM %
- 22
- Other Income
- 147
- Interest
- 63
- Depreciation
- 373
- 1,615
- Tax %
- 8
- Net Profit
- 1,486
- EPS
- 15
- Dividend Payout %
- 22
- Minority Interest
- -29
- Share of Associates
- 34
- Adjusted EPS
- 15
- Minority Interest
- -29
- Share of Associates
- 34
- Adjusted EPS
- 15
Mar 2018
- 11,905
- 9,058
- Operating Profit
- 2,980
- OPM %
- 25
- Other Income
- 133
- Interest
- 111
- Depreciation
- 539
- 2,331
- Tax %
- 24
- Net Profit
- 1,766
- EPS
- 17
- Dividend Payout %
- 20
- Minority Interest
- -35
- Share of Associates
- 63
- Adjusted EPS
- 17
- Minority Interest
- -35
- Share of Associates
- 63
- Adjusted EPS
- 17
Mar 2019
- 13,166
- 10,187
- Operating Profit
- 3,187
- OPM %
- 24
- Other Income
- 208
- Interest
- 196
- Depreciation
- 599
- 2,382
- Tax %
- 22
- Net Profit
- 1,852
- EPS
- 18
- Dividend Payout %
- 19
- Minority Interest
- -50
- Share of Associates
- 47
- Adjusted EPS
- 18
- Minority Interest
- -50
- Share of Associates
- 47
- Adjusted EPS
- 18
Mar 2020
- 14,253
- 11,473
- Operating Profit
- 2,897
- OPM %
- 20
- Other Income
- 117
- Interest
- 342
- Depreciation
- 696
- 1,495
- Tax %
- 21
- Net Profit
- 1,176
- EPS
- 11
- Dividend Payout %
- 30
- Minority Interest
- -28
- Share of Associates
- 29
- Adjusted EPS
- 11
- Minority Interest
- -28
- Share of Associates
- 29
- Adjusted EPS
- 11
Mar 2021
- 14,404
- 11,018
- Operating Profit
- 3,460
- OPM %
- 24
- Other Income
- 75
- Interest
- 186
- Depreciation
- 670
- 2,399
- Tax %
- 8
- Net Profit
- 2,206
- EPS
- 21
- Dividend Payout %
- 17
- Minority Interest
- -51
- Share of Associates
- 47
- Adjusted EPS
- 21
- Minority Interest
- -51
- Share of Associates
- 47
- Adjusted EPS
- 21
Mar 2022
- 15,110
- 11,935
- Operating Profit
- 3,565
- OPM %
- 24
- Other Income
- 391
- Interest
- 127
- Depreciation
- 713
- 2,838
- Tax %
- 18
- Net Profit
- 2,326
- EPS
- 44
- Dividend Payout %
- 6
- Minority Interest
- -131
- Share of Associates
- 46
- Adjusted EPS
- 44
- Minority Interest
- -131
- Share of Associates
- 46
- Adjusted EPS
- 44
Mar 2023
- 17,237
- 13,666
- Operating Profit
- 4,046
- OPM %
- 23
- Other Income
- 475
- Interest
- 130
- Depreciation
- 723
- 2,590
- Tax %
- 23
- Net Profit
- 2,002
- EPS
- 19
- Dividend Payout %
- 31
- Minority Interest
- -132
- Share of Associates
- 95
- Adjusted EPS
- 19
- Minority Interest
- -132
- Share of Associates
- 95
- Adjusted EPS
- 19
Mar 2024
- 19,547
- 14,248
- Operating Profit
- 5,668
- OPM %
- 29
- Other Income
- 369
- Interest
- 81
- Depreciation
- 764
- 4,809
- Tax %
- 20
- Net Profit
- 3,831
- EPS
- 38
- Dividend Payout %
- 8
- Minority Interest
- -113
- Share of Associates
- 118
- Adjusted EPS
- 38
- Minority Interest
- -113
- Share of Associates
- 118
- Adjusted EPS
- 38
Mar 2025
- 23,242
- 16,348
- Operating Profit
- 7,353
- OPM %
- 32
- Other Income
- 460
- Interest
- 191
- Depreciation
- 916
- 6,027
- Tax %
- 23
- Net Profit
- 4,615
- EPS
- 45
- Dividend Payout %
- 24
- Minority Interest
- -147
- Share of Associates
- 58
- Adjusted EPS
- 45
- Minority Interest
- -147
- Share of Associates
- 58
- Adjusted EPS
- 45
Mar 2026
- 27,148
- 19,958
- Operating Profit
- 8,985
- OPM %
- 33
- Other Income
- 1,795
- Interest
- 439
- Depreciation
- 1,408
- 6,621
- Tax %
- 24
- Net Profit
- 5,026
- EPS
- 50
- Dividend Payout %
- 2
- Minority Interest
- -84
- Share of Associates
- 97
- Adjusted EPS
- 50
- Minority Interest
- -84
- Share of Associates
- 97
- Adjusted EPS
- 50
TTM
- 28,270
- 22,045
- Operating Profit
- —
- OPM %
- —
- Other Income
- 1,520
- Interest
- 510
- Depreciation
- 1,725
- 6,045
- Tax %
- 25
- Net Profit
- 4,530
- EPS
- —
- Dividend Payout %
- —
- Minority Interest
- 48
- Share of Associates
- 100
- Adjusted EPS
- —
- Minority Interest
- 48
- Share of Associates
- 100
- Adjusted EPS
- —
COMPOUNDED SALES GROWTH
- 10 Years:
- 11%
- 5 Years:
- 14%
- 3 Years:
- 16%
COMPOUNDED PROFIT GROWTH
- 10 Years:
- 10%
- 5 Years:
- 19%
- 3 Years:
- 37%
STOCK PRICE CAGR
- 10 Years:
- 12%
- 5 Years:
- 16%
- 3 Years:
- 19%
- 1 Year:
- 13%
RETURN ON EQUITY
- 10 Years:
- 18%
- 5 Years:
- 18%
- 3 Years:
- 20%
- Last Year:
- 20%
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| LIABILITIES | - | - | - | - | - | - | - | - | - | - |
| Equity Capital | 102 | 102 | 102 | 102 | 102 | 102 | 101 | 101 | 101 | 101 |
| 6,858 | 8,642 | 10,284 | 10,273 | 12,890 | 16,897 | 17,415 | 19,729 | 23,852 | 27,011 | |
| 2,585 | 2,675 | 3,833 | 4,267 | 3,071 | 3,314 | 1,081 | 769 | 3,170 | 4,402 | |
| Trade Payables | 1,548 | 1,888 | 1,923 | 2,044 | 2,206 | 2,138 | 2,125 | 2,127 | 2,281 | 2,845 |
| 3,232 | 3,833 | 6,371 | 6,147 | 4,541 | 4,248 | 3,772 | 4,912 | 5,455 | 15,940 | |
| Total Liabilities | 14,325 | 17,141 | 22,513 | 22,834 | 22,810 | 26,700 | 24,494 | 27,637 | 34,858 | 50,298 |
| ASSETS | - | - | - | - | - | - | - | - | - | - |
| 5,755 | 6,483 | 12,164 | 12,230 | 12,133 | 12,188 | 11,521 | 12,368 | 13,134 | 24,106 | |
| Capital Work in Progress | 1,543 | 1,527 | 837 | 742 | 783 | 661 | 1,130 | 1,112 | 1,318 | 1,166 |
| 435 | 746 | 674 | 765 | 830 | 3,288 | 1,547 | 1,220 | 6,412 | 7,540 | |
| 1,804 | 2,385 | 2,688 | 2,789 | 3,236 | 3,719 | 3,413 | 3,442 | 3,944 | 5,628 | |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5,220 | 4,085 | 5,416 | |
| Cash & Bank | 1,544 | 1,315 | 549 | 965 | 888 | 1,107 | 573 | 1,105 | 2,957 | 1,417 |
| 3,245 | 4,685 | 5,601 | 5,343 | 4,940 | 5,736 | 6,310 | 3,169 | 3,009 | 5,026 | |
| Total Assets | 14,325 | 17,141 | 22,513 | 22,834 | 22,810 | 26,700 | 24,494 | 27,637 | 34,858 | 50,298 |
| Total Debt | 5,207 | 5,407 | 7,899 | 7,999 | 4,584 | 4,196 | 1,163 | 769 | 3,170 | 11,770 |
| Net Working Capital | 716 | 2,128 | 1,156 | 446 | 855 | 4,268 | 4,482 | 6,080 | 8,004 | 4,194 |
| Contingent Liabilities | 199 | 292 | 460 | 674 | 657 | 656 | 801 | 753 | 732 | 990 |
| Book Value per Share | 67.97 | 85.40 | 101.43 | 101.33 | 126.88 | 166.01 | 173.08 | 197.11 | 238.10 | 269.50 |
| Face Value | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Total Debt | 5,207 | 5,407 | 7,899 | 7,999 | 4,584 | 4,196 | 1,163 | 769 | 3,170 | 11,770 |
| Net Working Capital | 716 | 2,128 | 1,156 | 446 | 855 | 4,268 | 4,482 | 6,080 | 8,004 | 4,194 |
| Contingent Liabilities | 199 | 292 | 460 | 674 | 657 | 656 | 801 | 753 | 732 | 990 |
| Book Value per Share | 67.97 | 85.40 | 101.43 | 101.33 | 126.88 | 166.01 | 173.08 | 197.11 | 238.10 | 269.50 |
| Face Value | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
Mar 2017
- Equity Capital
- 102
- 6,858
- 2,585
- Trade Payables
- 1,548
- 3,232
- Total Liabilities
- 14,325
- 5,755
- Capital Work in Progress
- 1,543
- 435
- 1,804
- 0
- Cash & Bank
- 1,544
- 3,245
- Total Assets
- 14,325
- Total Debt
- 5,207
- Net Working Capital
- 716
- Contingent Liabilities
- 199
- Book Value per Share
- 67.97
- Face Value
- 1.00
- Total Debt
- 5,207
- Net Working Capital
- 716
- Contingent Liabilities
- 199
- Book Value per Share
- 67.97
- Face Value
- 1.00
Mar 2018
- Equity Capital
- 102
- 8,642
- 2,675
- Trade Payables
- 1,888
- 3,833
- Total Liabilities
- 17,141
- 6,483
- Capital Work in Progress
- 1,527
- 746
- 2,385
- 0
- Cash & Bank
- 1,315
- 4,685
- Total Assets
- 17,141
- Total Debt
- 5,407
- Net Working Capital
- 2,128
- Contingent Liabilities
- 292
- Book Value per Share
- 85.40
- Face Value
- 1.00
- Total Debt
- 5,407
- Net Working Capital
- 2,128
- Contingent Liabilities
- 292
- Book Value per Share
- 85.40
- Face Value
- 1.00
Mar 2019
- Equity Capital
- 102
- 10,284
- 3,833
- Trade Payables
- 1,923
- 6,371
- Total Liabilities
- 22,513
- 12,164
- Capital Work in Progress
- 837
- 674
- 2,688
- 0
- Cash & Bank
- 549
- 5,601
- Total Assets
- 22,513
- Total Debt
- 7,899
- Net Working Capital
- 1,156
- Contingent Liabilities
- 460
- Book Value per Share
- 101.43
- Face Value
- 1.00
- Total Debt
- 7,899
- Net Working Capital
- 1,156
- Contingent Liabilities
- 460
- Book Value per Share
- 101.43
- Face Value
- 1.00
Mar 2020
- Equity Capital
- 102
- 10,273
- 4,267
- Trade Payables
- 2,044
- 6,147
- Total Liabilities
- 22,834
- 12,230
- Capital Work in Progress
- 742
- 765
- 2,789
- 0
- Cash & Bank
- 965
- 5,343
- Total Assets
- 22,834
- Total Debt
- 7,999
- Net Working Capital
- 446
- Contingent Liabilities
- 674
- Book Value per Share
- 101.33
- Face Value
- 1.00
- Total Debt
- 7,999
- Net Working Capital
- 446
- Contingent Liabilities
- 674
- Book Value per Share
- 101.33
- Face Value
- 1.00
Mar 2021
- Equity Capital
- 102
- 12,890
- 3,071
- Trade Payables
- 2,206
- 4,541
- Total Liabilities
- 22,810
- 12,133
- Capital Work in Progress
- 783
- 830
- 3,236
- 0
- Cash & Bank
- 888
- 4,940
- Total Assets
- 22,810
- Total Debt
- 4,584
- Net Working Capital
- 855
- Contingent Liabilities
- 657
- Book Value per Share
- 126.88
- Face Value
- 1.00
- Total Debt
- 4,584
- Net Working Capital
- 855
- Contingent Liabilities
- 657
- Book Value per Share
- 126.88
- Face Value
- 1.00
Mar 2022
- Equity Capital
- 102
- 16,897
- 3,314
- Trade Payables
- 2,138
- 4,248
- Total Liabilities
- 26,700
- 12,188
- Capital Work in Progress
- 661
- 3,288
- 3,719
- 0
- Cash & Bank
- 1,107
- 5,736
- Total Assets
- 26,700
- Total Debt
- 4,196
- Net Working Capital
- 4,268
- Contingent Liabilities
- 656
- Book Value per Share
- 166.01
- Face Value
- 1.00
- Total Debt
- 4,196
- Net Working Capital
- 4,268
- Contingent Liabilities
- 656
- Book Value per Share
- 166.01
- Face Value
- 1.00
Mar 2023
- Equity Capital
- 101
- 17,415
- 1,081
- Trade Payables
- 2,125
- 3,772
- Total Liabilities
- 24,494
- 11,521
- Capital Work in Progress
- 1,130
- 1,547
- 3,413
- 0
- Cash & Bank
- 573
- 6,310
- Total Assets
- 24,494
- Total Debt
- 1,163
- Net Working Capital
- 4,482
- Contingent Liabilities
- 801
- Book Value per Share
- 173.08
- Face Value
- 1.00
- Total Debt
- 1,163
- Net Working Capital
- 4,482
- Contingent Liabilities
- 801
- Book Value per Share
- 173.08
- Face Value
- 1.00
Mar 2024
- Equity Capital
- 101
- 19,729
- 769
- Trade Payables
- 2,127
- 4,912
- Total Liabilities
- 27,637
- 12,368
- Capital Work in Progress
- 1,112
- 1,220
- 3,442
- 5,220
- Cash & Bank
- 1,105
- 3,169
- Total Assets
- 27,637
- Total Debt
- 769
- Net Working Capital
- 6,080
- Contingent Liabilities
- 753
- Book Value per Share
- 197.11
- Face Value
- 1.00
- Total Debt
- 769
- Net Working Capital
- 6,080
- Contingent Liabilities
- 753
- Book Value per Share
- 197.11
- Face Value
- 1.00
Mar 2025
- Equity Capital
- 101
- 23,852
- 3,170
- Trade Payables
- 2,281
- 5,455
- Total Liabilities
- 34,858
- 13,134
- Capital Work in Progress
- 1,318
- 6,412
- 3,944
- 4,085
- Cash & Bank
- 2,957
- 3,009
- Total Assets
- 34,858
- Total Debt
- 3,170
- Net Working Capital
- 8,004
- Contingent Liabilities
- 732
- Book Value per Share
- 238.10
- Face Value
- 1.00
- Total Debt
- 3,170
- Net Working Capital
- 8,004
- Contingent Liabilities
- 732
- Book Value per Share
- 238.10
- Face Value
- 1.00
Mar 2026
- Equity Capital
- 101
- 27,011
- 4,402
- Trade Payables
- 2,845
- 15,940
- Total Liabilities
- 50,298
- 24,106
- Capital Work in Progress
- 1,166
- 7,540
- 5,628
- 5,416
- Cash & Bank
- 1,417
- 5,026
- Total Assets
- 50,298
- Total Debt
- 11,770
- Net Working Capital
- 4,194
- Contingent Liabilities
- 990
- Book Value per Share
- 269.50
- Face Value
- 1.00
- Total Debt
- 11,770
- Net Working Capital
- 4,194
- Contingent Liabilities
- 990
- Book Value per Share
- 269.50
- Face Value
- 1.00
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| 1,312 | 919 | 1,282 | 2,932 | 3,294 | 2,104 | 2,689 | 3,196 | 6,781 | 2,117 | |
| Cash from Investing | -2,872 | -974 | -4,239 | -1,012 | -725 | -1,000 | 1,535 | -1,475 | -8,358 | -8,296 |
| Cash from Financing | 2,316 | 52 | 1,885 | -1,528 | -2,548 | -868 | -4,400 | -1,779 | 1,995 | 5,807 |
| 756 | -3 | -1,072 | 391 | 22 | 236 | -177 | -58 | 419 | -373 | |
| Free Cash Flow | -1,616 | -311 | -4,381 | 1,948 | 2,689 | 1,921 | 1,527 | 1,639 | 4,795 | -10,341 |
| OCF / Net Profit | 0.88 | 0.52 | 0.69 | 2.49 | 1.49 | 0.90 | 1.34 | 0.83 | 1.47 | 0.42 |
| Cumulative 5-Year FCF | 0 | 0 | 0 | 0 | -1,672 | 1,865 | 3,703 | 9,723 | 12,570 | -460 |
| OCF / Net Profit | 0.88 | 0.52 | 0.69 | 2.49 | 1.49 | 0.90 | 1.34 | 0.83 | 1.47 | 0.42 |
| Cumulative 5-Year FCF | 0 | 0 | 0 | 0 | -1,672 | 1,865 | 3,703 | 9,723 | 12,570 | -460 |
Mar 2017
- 1,312
- Cash from Investing
- -2,872
- Cash from Financing
- 2,316
- 756
- Free Cash Flow
- -1,616
- OCF / Net Profit
- 0.88
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 0.88
- Cumulative 5-Year FCF
- 0
Mar 2018
- 919
- Cash from Investing
- -974
- Cash from Financing
- 52
- -3
- Free Cash Flow
- -311
- OCF / Net Profit
- 0.52
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 0.52
- Cumulative 5-Year FCF
- 0
Mar 2019
- 1,282
- Cash from Investing
- -4,239
- Cash from Financing
- 1,885
- -1,072
- Free Cash Flow
- -4,381
- OCF / Net Profit
- 0.69
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 0.69
- Cumulative 5-Year FCF
- 0
Mar 2020
- 2,932
- Cash from Investing
- -1,012
- Cash from Financing
- -1,528
- 391
- Free Cash Flow
- 1,948
- OCF / Net Profit
- 2.49
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 2.49
- Cumulative 5-Year FCF
- 0
Mar 2021
- 3,294
- Cash from Investing
- -725
- Cash from Financing
- -2,548
- 22
- Free Cash Flow
- 2,689
- OCF / Net Profit
- 1.49
- Cumulative 5-Year FCF
- -1,672
- OCF / Net Profit
- 1.49
- Cumulative 5-Year FCF
- -1,672
Mar 2022
- 2,104
- Cash from Investing
- -1,000
- Cash from Financing
- -868
- 236
- Free Cash Flow
- 1,921
- OCF / Net Profit
- 0.90
- Cumulative 5-Year FCF
- 1,865
- OCF / Net Profit
- 0.90
- Cumulative 5-Year FCF
- 1,865
Mar 2023
- 2,689
- Cash from Investing
- 1,535
- Cash from Financing
- -4,400
- -177
- Free Cash Flow
- 1,527
- OCF / Net Profit
- 1.34
- Cumulative 5-Year FCF
- 3,703
- OCF / Net Profit
- 1.34
- Cumulative 5-Year FCF
- 3,703
Mar 2024
- 3,196
- Cash from Investing
- -1,475
- Cash from Financing
- -1,779
- -58
- Free Cash Flow
- 1,639
- OCF / Net Profit
- 0.83
- Cumulative 5-Year FCF
- 9,723
- OCF / Net Profit
- 0.83
- Cumulative 5-Year FCF
- 9,723
Mar 2025
- 6,781
- Cash from Investing
- -8,358
- Cash from Financing
- 1,995
- 419
- Free Cash Flow
- 4,795
- OCF / Net Profit
- 1.47
- Cumulative 5-Year FCF
- 12,570
- OCF / Net Profit
- 1.47
- Cumulative 5-Year FCF
- 12,570
Mar 2026
- 2,117
- Cash from Investing
- -8,296
- Cash from Financing
- 5,807
- -373
- Free Cash Flow
- -10,341
- OCF / Net Profit
- 0.42
- Cumulative 5-Year FCF
- -460
- OCF / Net Profit
- 0.42
- Cumulative 5-Year FCF
- -460
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| PER SHARE | - | - | - | - | - | - | - | - | - | - |
| EPS (₹) | 14.53 | 17.34 | 18.05 | 11.49 | 20.84 | 43.82 | 19.37 | 38.36 | 44.99 | 50.10 |
| Book Value (₹) | 67.97 | 85.40 | 101.43 | 101.33 | 126.88 | 166.01 | 173.08 | 197.11 | 238.10 | 269.50 |
| Dividend per Share (₹) | 3.20 | 3.50 | 3.50 | 3.50 | 3.50 | 2.50 | 6.00 | 3.00 | 11.00 | 1.00 |
| Cash EPS (₹) | 18.15 | 22.51 | 23.93 | 18.28 | 28.08 | 29.68 | 26.92 | 45.68 | 54.98 | 63.96 |
| PROFITABILITY | - | - | - | - | - | - | - | - | - | - |
| Operating Margin % | 21.43% | 24.93% | 24.21% | 20.33% | 11.98% | 12.06% | 11.93% | 13.97% | 15.09% | 13.91% |
| Net Margin % | 15.52% | 14.78% | 14.07% | 8.25% | 7.64% | 7.87% | 5.90% | 10.10% | 10.10% | 9.73% |
| ROE % | 23.47% | 22.50% | 19.36% | 11.32% | 18.88% | 15.51% | 11.60% | 20.52% | 21.08% | 19.69% |
| ROCE % | 16.52% | 18.55% | 15.89% | 10.02% | 14.38% | 15.30% | 13.64% | 24.90% | 26.06% | 21.39% |
| 12.20% | 11.23% | 9.34% | 5.18% | 9.66% | 9.40% | 7.82% | 14.70% | 14.77% | 11.81% | |
| EFFICIENCY | - | - | - | - | - | - | - | - | - | - |
| Debtor Days | 77 | 84 | 99 | 97 | 43 | 40 | 42 | 46 | 37 | 34 |
| Inventory Days | 60 | 64 | 70 | 70 | 38 | 43 | 38 | 33 | 30 | 34 |
| Payable Days | 170 | 171 | 168 | 171 | 189 | 167 | 146 | 148 | 150 | 150 |
| -33 | -24 | 2 | -3 | -108 | -84 | -66 | -68 | -84 | -82 | |
| FINANCIAL HEALTH | - | - | - | - | - | - | - | - | - | - |
| Debt to Equity (x) | 0.75x | 0.62x | 0.76x | 0.77x | 0.35x | 0.25x | 0.07x | 0.04x | 0.13x | 0.43x |
| Interest Coverage (x) | 26.59x | 22.04x | 13.17x | 5.38x | 13.87x | 23.35x | 20.94x | 60.22x | 32.55x | 16.09x |
| 1.14x | 1.35x | 1.16x | 1.05x | 1.11x | 1.55x | 1.81x | 2.14x | 1.89x | 1.27x | |
| GROWTH | - | - | - | - | - | - | - | - | - | - |
| Revenue Growth % | -0.53% | 26.97% | 10.59% | 8.26% | 1.06% | 4.90% | 14.08% | 13.40% | 18.90% | 16.81% |
| Operating Profit Growth % | -16.14% | 45.29% | 6.93% | -9.09% | 19.43% | 3.04% | 13.49% | 40.08% | 29.72% | 22.19% |
| Net Profit Growth % | -22.67% | 18.89% | 4.83% | -36.52% | 87.61% | 5.48% | -13.95% | 91.39% | 20.45% | 8.92% |
| 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 98.06% | 17.26% | 11.37% | |
| VALUATION | - | - | - | - | - | - | - | - | - | - |
| P/E (x) | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 26.20x | 19.69x | 17.39x |
| P/B (x) | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 5.10x | 3.72x | 3.23x |
| Dividend Yield % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.30% | 1.24% | 0.11% |
| 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 17.78x | 12.15x | 10.91x |
Mar 2017
- EPS (₹)
- 14.53
- Book Value (₹)
- 67.97
- Dividend per Share (₹)
- 3.20
- Cash EPS (₹)
- 18.15
- Operating Margin %
- 21.43%
- Net Margin %
- 15.52%
- ROE %
- 23.47%
- ROCE %
- 16.52%
- 12.20%
- Debtor Days
- 77
- Inventory Days
- 60
- Payable Days
- 170
- -33
- Debt to Equity (x)
- 0.75x
- Interest Coverage (x)
- 26.59x
- 1.14x
- Revenue Growth %
- -0.53%
- Operating Profit Growth %
- -16.14%
- Net Profit Growth %
- -22.67%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2018
- EPS (₹)
- 17.34
- Book Value (₹)
- 85.40
- Dividend per Share (₹)
- 3.50
- Cash EPS (₹)
- 22.51
- Operating Margin %
- 24.93%
- Net Margin %
- 14.78%
- ROE %
- 22.50%
- ROCE %
- 18.55%
- 11.23%
- Debtor Days
- 84
- Inventory Days
- 64
- Payable Days
- 171
- -24
- Debt to Equity (x)
- 0.62x
- Interest Coverage (x)
- 22.04x
- 1.35x
- Revenue Growth %
- 26.97%
- Operating Profit Growth %
- 45.29%
- Net Profit Growth %
- 18.89%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2019
- EPS (₹)
- 18.05
- Book Value (₹)
- 101.43
- Dividend per Share (₹)
- 3.50
- Cash EPS (₹)
- 23.93
- Operating Margin %
- 24.21%
- Net Margin %
- 14.07%
- ROE %
- 19.36%
- ROCE %
- 15.89%
- 9.34%
- Debtor Days
- 99
- Inventory Days
- 70
- Payable Days
- 168
- 2
- Debt to Equity (x)
- 0.76x
- Interest Coverage (x)
- 13.17x
- 1.16x
- Revenue Growth %
- 10.59%
- Operating Profit Growth %
- 6.93%
- Net Profit Growth %
- 4.83%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2020
- EPS (₹)
- 11.49
- Book Value (₹)
- 101.33
- Dividend per Share (₹)
- 3.50
- Cash EPS (₹)
- 18.28
- Operating Margin %
- 20.33%
- Net Margin %
- 8.25%
- ROE %
- 11.32%
- ROCE %
- 10.02%
- 5.18%
- Debtor Days
- 97
- Inventory Days
- 70
- Payable Days
- 171
- -3
- Debt to Equity (x)
- 0.77x
- Interest Coverage (x)
- 5.38x
- 1.05x
- Revenue Growth %
- 8.26%
- Operating Profit Growth %
- -9.09%
- Net Profit Growth %
- -36.52%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2021
- EPS (₹)
- 20.84
- Book Value (₹)
- 126.88
- Dividend per Share (₹)
- 3.50
- Cash EPS (₹)
- 28.08
- Operating Margin %
- 11.98%
- Net Margin %
- 7.64%
- ROE %
- 18.88%
- ROCE %
- 14.38%
- 9.66%
- Debtor Days
- 43
- Inventory Days
- 38
- Payable Days
- 189
- -108
- Debt to Equity (x)
- 0.35x
- Interest Coverage (x)
- 13.87x
- 1.11x
- Revenue Growth %
- 1.06%
- Operating Profit Growth %
- 19.43%
- Net Profit Growth %
- 87.61%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2022
- EPS (₹)
- 43.82
- Book Value (₹)
- 166.01
- Dividend per Share (₹)
- 2.50
- Cash EPS (₹)
- 29.68
- Operating Margin %
- 12.06%
- Net Margin %
- 7.87%
- ROE %
- 15.51%
- ROCE %
- 15.30%
- 9.40%
- Debtor Days
- 40
- Inventory Days
- 43
- Payable Days
- 167
- -84
- Debt to Equity (x)
- 0.25x
- Interest Coverage (x)
- 23.35x
- 1.55x
- Revenue Growth %
- 4.90%
- Operating Profit Growth %
- 3.04%
- Net Profit Growth %
- 5.48%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2023
- EPS (₹)
- 19.37
- Book Value (₹)
- 173.08
- Dividend per Share (₹)
- 6.00
- Cash EPS (₹)
- 26.92
- Operating Margin %
- 11.93%
- Net Margin %
- 5.90%
- ROE %
- 11.60%
- ROCE %
- 13.64%
- 7.82%
- Debtor Days
- 42
- Inventory Days
- 38
- Payable Days
- 146
- -66
- Debt to Equity (x)
- 0.07x
- Interest Coverage (x)
- 20.94x
- 1.81x
- Revenue Growth %
- 14.08%
- Operating Profit Growth %
- 13.49%
- Net Profit Growth %
- -13.95%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2024
- EPS (₹)
- 38.36
- Book Value (₹)
- 197.11
- Dividend per Share (₹)
- 3.00
- Cash EPS (₹)
- 45.68
- Operating Margin %
- 13.97%
- Net Margin %
- 10.10%
- ROE %
- 20.52%
- ROCE %
- 24.90%
- 14.70%
- Debtor Days
- 46
- Inventory Days
- 33
- Payable Days
- 148
- -68
- Debt to Equity (x)
- 0.04x
- Interest Coverage (x)
- 60.22x
- 2.14x
- Revenue Growth %
- 13.40%
- Operating Profit Growth %
- 40.08%
- Net Profit Growth %
- 91.39%
- 98.06%
- P/E (x)
- 26.20x
- P/B (x)
- 5.10x
- Dividend Yield %
- 0.30%
- 17.78x
Mar 2025
- EPS (₹)
- 44.99
- Book Value (₹)
- 238.10
- Dividend per Share (₹)
- 11.00
- Cash EPS (₹)
- 54.98
- Operating Margin %
- 15.09%
- Net Margin %
- 10.10%
- ROE %
- 21.08%
- ROCE %
- 26.06%
- 14.77%
- Debtor Days
- 37
- Inventory Days
- 30
- Payable Days
- 150
- -84
- Debt to Equity (x)
- 0.13x
- Interest Coverage (x)
- 32.55x
- 1.89x
- Revenue Growth %
- 18.90%
- Operating Profit Growth %
- 29.72%
- Net Profit Growth %
- 20.45%
- 17.26%
- P/E (x)
- 19.69x
- P/B (x)
- 3.72x
- Dividend Yield %
- 1.24%
- 12.15x
Mar 2026
- EPS (₹)
- 50.10
- Book Value (₹)
- 269.50
- Dividend per Share (₹)
- 1.00
- Cash EPS (₹)
- 63.96
- Operating Margin %
- 13.91%
- Net Margin %
- 9.73%
- ROE %
- 19.69%
- ROCE %
- 21.39%
- 11.81%
- Debtor Days
- 34
- Inventory Days
- 34
- Payable Days
- 150
- -82
- Debt to Equity (x)
- 0.43x
- Interest Coverage (x)
- 16.09x
- 1.27x
- Revenue Growth %
- 16.81%
- Operating Profit Growth %
- 22.19%
- Net Profit Growth %
- 8.92%
- 11.37%
- P/E (x)
- 17.39x
- P/B (x)
- 3.23x
- Dividend Yield %
- 0.11%
- 10.91x
Documents
Announcements
- Analysts/Institutional Investor Meet/Con. Call Updates
2026-08-18 - Zydus Lifesciences Limited has informed the Exchange about Transcript
- Analysts/Institutional Investor Meet/Con. Call Updates
2026-08-17 - Zydus Lifesciences Limited has informed the Exchange about Schedule of meet
Annual Reports
Credit Ratings
Nothing filed yet.
Concalls
Aug 2026
May 2026
Feb 2026